Correction: Equity in clinical trials for HIV-associated cryptococcal meningitis: A systematic review of global representation and inclusion of patients and researchersdoi:10.1371/journal.pntd.0011240CLINICAL trialsMENINGITISJOINTS (Anatomy)MEDICAL research...
The company is investigating ways to further equity in clinical trials in other countries where we conduct such research. “We’ve made advances, but there’s still more to do,” said Hirawat. “Remembering that keeps us inspired and motivated.” ...
In particular, pharmacists and pharmacy students have a duty to improve women’s participation in clinical trials so we can provide our patients with the safest medical decisions. A Brief History of Women's Inclusion in Clinical Trials Women’s participation in clinical research has come a long ...
Over the last several years, Lilly has advanced itswork in health equity, including enhancing diversity in clinical trials, increasingaccess to and affordability of its medicines, collaborating with patient advocacy groups, and expanding education and employment opportunities for individua...
Clinical trials should represent the patients who will ultimately use a treatment. Diversity in clinical trials helps to inform the evaluation of safety and effectiveness of new medicines. It can also address health inequities that come from lack of access to potentially lifesaving treatments. ...
on patients. These panels should include not only clinicians and ethicists but also people knowledgeable about the economic and clinical effects of corporate acquisitions on patient care. Given the scale and scope of this issue, generalist professional societies could take the lead in convening panels...
, and UCB is working to find new ways to connect to unique patient populations through digital and data-driven approaches as well as connecting in communities. Learn more aboutUCB’s approach to diversity in clinical trialsand some of the ways we areimproving representation in clinical trials....
最初的 CONSORT 声 明主要针对两组平行干预的 RCT,随后陆续完成制 作并发表了涉及其他设计类型的临床试验 CONSORT 扩展版,其中包括由我国学者参与并制定的,针对 中医药临床试验的 CONSORT-STRICTA(Revised Standards for Reporting Interventions in Clinical Trials of Acupuncture: Extending the CONSORT Statement)[10]...
Increasing Diversity, Equity, Inclusion, and Accessibility in Rare Disease Clinical Trials Diversity, equity, inclusion, and accessibility (DEIA) are foundational principles for clinical trials and medical research. In rare diseases clinical rese... G Baynam,S Baker,C Steward,... - 《Pharmaceutical...
Our clinical development pipeline In a challenging environment, our pipeline builds the basis of UCB’s sustainable long-term growth. We continued to create value for patients, advancing our pipeline of potential solutions for severe diseases, expanding our capabilities by investing in state-of-the-...